Skip to main content
. 2024 Nov 28;32(1):e16542. doi: 10.1111/ene.16542

FIGURE 2.

FIGURE 2

(a) ∆ Mean monthly migraine days and (b) ∆ mean monthly headache days with 95% CI from baseline and 3 months’ follow‐up in the switcher (n = 31) and control group (n = 36).